| Phase 11 trial |
|
Phase 1
|
NCT01585415 |
Apr 2012 → Jul 2016 |
melanoma, metastatic malignant neoplasm |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
| Phase 26 trials |
|
Phase 2
|
NCT02621021 |
Dec 2015 → Jun 2028 expected |
melanoma |
National Cancer Institute (NCI) |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT02133196 |
Oct 2014 → Oct 2027 expected |
adenocarcinoma, adenosquamous carcinoma, non-small cell lung carcinoma |
National Cancer Institute (NCI) |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT01993719 |
Dec 2013 → Oct 2021 |
metastatic melanoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01585428 |
Apr 2012 → Apr 2016 |
anus cancer, cervical cancer, oropharyngeal carcinoma, penile cancer +1 |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01319565 |
Mar 2011 → Sep 2024 |
metastatic melanoma, skin cancer |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01174121 |
Aug 2010 → Dec 2028 expected |
breast carcinoma, colorectal cancer, malignant pancreatic neoplasm, neuroendocrine neoplasm +1 |
National Cancer Institute (NCI) |
Recruiting
|
No outcome recorded
|